AcouSort
19.25 SEK +2.94%Be the first to follow this company
AcouSort is active within medical technology. The company conducts research and development in a proprietary platform technology that utilises ultrasound to separate and analyse composition of biological cells. The technology is mainly used in the analysis of various cases of cancer as well as sepsis. Part of the research is done together with other stakeholders within field. The company was founded in 2010 and is based in Lund.
Revenue
-
EBIT %
-
P/E
-
Dividend yield-%
-
Target price
-
Recommendation
-
Updated
-
First North Stockholm
ACOU
Daily low / high price
18.6 / 19.5
SEK
Market cap
287.48M SEK
Turnover
625.1K SEK
Volume
33K
Financial calendar
Interim report
28.08.2024
Interim report
27.11.2024
Annual report
26.02.2025
Major OwnersSource: Millistream Market Data AB
Owner | Capital | Votes |
---|---|---|
Avanza Pension | 10.7 % | 10.7 % |
Thomas Laurell | 7.4 % | 7.4 % |
Premium
This content is for our Premium customers only.
ShowingAll content types
AcouSort and GenSensor collaboration develops according to plan
AcouSort to participate in a pioneering project to release the potential in extracellular vesicles research
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools